Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 89110313

LYPD3, Rabbit, Clone: SP204, Abnova™

Catalog No. 89110313 Shop All Abnova Corporation Products
Change view
Click to view available options
Quantity:
100 μL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
89-110-313 100 μL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 89-110-313 Supplier Abnova Corporation Supplier No. MAB12172

Description

Rabbit monoclonal antibody raised against synthetic peptide of human LYPD3.

Specifications

Antigen LYPD3
Applications Immunohistochemistry (PFA fixed)
Classification Monoclonal
Clone SP204
Conjugate Unconjugated
Description Rabbit monoclonal antibody raised against synthetic peptide of human LYPD3.
Dilution Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1:100) The optimal working dilution should be determined by the end user.
Formulation In 10mM PBS, pH 7.6 (1% BSA, 0.09% sodium azide)
Gene LYPD3
Gene Alias C4.4A
Gene Symbols LYPD3
Host Species Rabbit
Immunogen A synthetic peptide corresponding to C-terminus region of human LYPD3.
Purification Method Protein A/G purification
Quantity 100 μL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 27076
Target Species Human
Content And Storage Store at 4°C.
Form Liquid
Isotype IgG
Show More Show Less

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.